Stryker (NYSE:SYK) Earns "Market Perform" Rating from JMP Securities

JMP Securities restated their market perform rating on shares of Stryker (NYSE:SYK - Free Report) in a report published on Tuesday,Benzinga reports.

A number of other equities analysts have also recently issued reports on the company. Stifel Nicolaus increased their price target on Stryker from $400.00 to $440.00 and gave the stock a "buy" rating in a report on Wednesday, January 29th. Needham & Company LLC reissued a "buy" rating and set a $442.00 target price on shares of Stryker in a research note on Wednesday, January 29th. JPMorgan Chase & Co. raised their price target on shares of Stryker from $420.00 to $445.00 and gave the stock an "overweight" rating in a report on Wednesday, January 29th. StockNews.com lowered shares of Stryker from a "buy" rating to a "hold" rating in a report on Thursday, January 30th. Finally, Citigroup raised their target price on Stryker from $411.00 to $450.00 and gave the company a "buy" rating in a research note on Wednesday, December 11th. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $420.68.

Stryker Trading Down 1.0 %

Shares of SYK traded down $3.82 during mid-day trading on Tuesday, reaching $382.59. 1,268,413 shares of the company were exchanged, compared to its average volume of 1,388,856. The business has a 50 day simple moving average of $378.07 and a two-hundred day simple moving average of $368.67. Stryker has a 52 week low of $314.93 and a 52 week high of $406.19. The stock has a market capitalization of $145.99 billion, a PE ratio of 49.30, a PEG ratio of 2.93 and a beta of 0.96. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 EPS for the quarter, beating analysts' consensus estimates of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same quarter in the previous year, the company earned $3.46 EPS. On average, analysts predict that Stryker will post 13.49 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be paid a $0.84 dividend. The ex-dividend date of this dividend is Monday, March 31st. This represents a $3.36 dividend on an annualized basis and a yield of 0.88%. Stryker's dividend payout ratio (DPR) is presently 43.30%.

Insider Transactions at Stryker

In other Stryker news, Director Ronda E. Stryker sold 201,392 shares of the firm's stock in a transaction on Friday, January 31st. The stock was sold at an average price of $392.24, for a total value of $78,993,998.08. Following the completion of the sale, the director now directly owns 3,642,075 shares of the company's stock, valued at $1,428,567,498. This trade represents a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Allan C. Golston sold 2,458 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total value of $941,586.06. Following the completion of the sale, the director now owns 14,895 shares in the company, valued at approximately $5,705,827.65. The trade was a 14.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 5.90% of the company's stock.

Institutional Investors Weigh In On Stryker

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Kohmann Bosshard Financial Services LLC bought a new stake in Stryker during the 4th quarter valued at $25,000. Dunhill Financial LLC raised its stake in shares of Stryker by 94.9% during the 3rd quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company's stock valued at $27,000 after purchasing an additional 37 shares during the period. Rakuten Securities Inc. lifted its holdings in Stryker by 618.2% during the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after purchasing an additional 68 shares in the last quarter. Centricity Wealth Management LLC purchased a new position in Stryker during the 4th quarter valued at about $30,000. Finally, BankPlus Trust Department bought a new stake in shares of Stryker during the fourth quarter valued at about $33,000. 77.09% of the stock is currently owned by institutional investors.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.